Some US FDA Advisory Committee Meetings Likely To Remain Virtual Post-Pandemic
Peter Stein says FDA will set criteria for holding a virtual meeting and will be seeking stakeholder feedback.
You may also be interested in...
With Congress watching whether enough experts are on advisory committees for orphan drugs, the US FDA may be pressured into changes.
Despite acknowledging that fully in-person meetings overall are better, survey respondents said they still want the flexibility that virtual attendance offers.
Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.